Technical Note: Relationships between gamma criteria and action levels: Results of a multicenter audit of gamma agreement index results
- 25 February 2016
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 43 (3) , 1501-1506
Abstract
Purpose: The aim of this work was to use a multicenter audit of modulated radiotherapy quality assurance (QA) data to provide a practical examination of gamma evaluation criteria and action level selection. The use of the gamma evaluation method for patient‐specific pretreatment QA is widespread, with most commercial solutions implementing the method.Methods: Gamma agreement indices were calculated using the criteria 1%/1 mm, 2%/2 mm, 2%/3 mm, 3%/2 mm, 3%/3 mm, and 5%/3 mm for 1265 pretreatment QA measurements, planned at seven treatment centers, using four different treatment planning systems, delivered using three different delivery systems (intensity‐modulated radiation therapy, volumetric‐modulated arc therapy, and helical tomotherapy) and measured using three different dose measurement systems. The sensitivity of each pair of gamma criteria was evaluated relative to the gamma agreement indices calculated using 3%/3 mm.Results: A linear relationship was observed for 2%/2 mm, 2%/3 mm, and 3%/2 mm. This result implies that most beams failing at 3%/3 mm would also fail for those criteria, if the action level was adjusted appropriately. Some borderline plans might be passed or failed depending on the relative priority (tighter tolerance) used for dose difference or distance to agreement evaluation. Dosimeter resolution and treatment modality were found to have a smaller effect on the results of QA measurements than the number of dimensions (2D or 3D) over which the gamma evaluation was calculated.Conclusions: This work provides a method (and a large sample of results) for calculating equivalent action levels for different gamma evaluation criteria. This work constitutes a valuable guide for clinical decision making and a means to compare published gamma evaluation results from studies using different evaluation criteria. More generally, the data provided by this work support the recommendation that gamma criteria that specifically prioritize the property of greatest clinical importance for each treatment modality of anatomical site should be selected when using gamma evaluations for modulated radiotherapy QA. It is therefore suggested that departments using the gamma evaluation as a QA analysis tool should consider the relative importance of dose difference and distance to agreement, when selecting gamma evaluation criteria.Keywords
Funding Information
- Australian Research Council (ARC) (LP110100401)
- Australian Research Council (LP110100401)
- Australian Research Council (LP110100401)
This publication has 33 references indexed in Scilit:
- A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systemsRadiotherapy and Oncology, 2013
- Evaluation of the ArcCHECK QA system for IMRT and VMAT verificationPhysica Medica, 2013
- A snapshot of radiation therapy techniques and technology in Queensland: An aid to mapping undergraduate curriculumJournal of Medical Radiation Sciences, 2013
- EBT2 radiochromic film for quality assurance of complex IMRT treatments of the prostate: micro-collimated IMRT, RapidArc, and TomoTherapyAustralasian Physics & Engineering Sciences in Medicine, 2011
- Intensity-modulated arc therapy: principles, technologies and clinical implementationPhysics in Medicine & Biology, 2011
- Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification within vivodosimetryBritish Journal of Radiology, 2010
- Evaluation of the Delta4phantom for IMRT and VMAT verificationPhysics in Medicine & Biology, 2009
- The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapyRadiation Oncology, 2008
- Establishing action levels for EPID‐based QA for IMRTJournal of Applied Clinical Medical Physics, 2008
- Intensity‐modulated radiation therapy use in the U.S., 2004Cancer, 2005